Carlson J H, Bergstrom D A, Demo S D, Walters J R
Physiological Neuropharmacology Section, National Institute of Neurological and Communicative Disorders and Stroke, Bethesda, MD 20892.
Eur J Pharmacol. 1988 Aug 2;152(3):289-300. doi: 10.1016/0014-2999(88)90724-8.
Extracellular single unit recording techniques were used to investigate dopamine agonist-induced changes in the tonic activity of globus pallidus neurons in normal control rats, and in rats in which dopamine levels were acutely reduced by alpha-methyl-para-tyrosine (AMPT) pretreatment. Systemic administration of the nonselective D-1/D-2 agonist apomorphine consistently induced large increases in the firing rates of globus pallidus neurons, as shown previously. The D-1 agonist SKF 38393 frequently induced no change in pallidal cell firing rates with doses up to 20 mg/kg; however, firing rates of 40% of the cells were stimulated by more than 20% of baseline and 14% were partially inhibited after 20 mg/kg SKF 38393. Following AMPT pretreatment, SKF 38393 induced only increases and no changes in activity; no decreases were observed. The D-2 agonist quinpirole typically increased pallidal neuron activity in a dose-dependent manner but was markedly less effective at stimulating pallidal neuron activity than apomorphine. In AMPT-treated rats, quinpirole's effects were significantly attenuated. Consistent with previous results, most cells showed large rate increases when SKF 38393 and quinpirole were coadministered to normal rats; these increases were similar in magnitude to those induced by apomorphine. In contrast to the observation that AMPT treatment altered the responses of globus pallidus neurons to individually administered quinpirole and SKF 38393, neither the increases in pallidal cell activity induced by apomorphine nor those induced by coadministration of SKF 38393 and quinpirole were significantly attenuated in AMPT-treated rats. The results support the idea that stimulation of both D-1 and D-2 receptors appears to be required to induce apomorphine-like changes in basal ganglia output. Moreover, the effects of individually administered D-1 and D-2 agonists observed in normal rats appear to depend upon the degree to which the complementary receptor subtype is stimulated by endogenous dopamine.
采用细胞外单单位记录技术,研究多巴胺激动剂对正常对照大鼠以及经α-甲基-对酪氨酸(AMPT)预处理使多巴胺水平急性降低的大鼠苍白球神经元紧张性活动的影响。如先前所示,非选择性D-1/D-2激动剂阿扑吗啡的全身给药持续引起苍白球神经元放电频率大幅增加。D-1激动剂SKF 38393剂量高达20mg/kg时,通常不会引起苍白球细胞放电频率改变;然而,20mg/kg SKF 38393给药后,40%的细胞放电频率被刺激超过基线的20%,14%的细胞放电频率被部分抑制。AMPT预处理后,SKF 38393仅引起活动增加,未出现改变;未观察到活动减少。D-2激动剂喹吡罗通常以剂量依赖性方式增加苍白球神经元活动,但在刺激苍白球神经元活动方面明显不如阿扑吗啡有效。在AMPT处理的大鼠中,喹吡罗的作用显著减弱。与先前结果一致,当SKF 38393和喹吡罗共同给予正常大鼠时,大多数细胞显示放电频率大幅增加;这些增加的幅度与阿扑吗啡诱导的相似。与AMPT处理改变苍白球神经元对单独给予喹吡罗和SKF 38393的反应这一观察结果相反,阿扑吗啡诱导的苍白球细胞活动增加以及SKF 38393和喹吡罗共同给药诱导的增加在AMPT处理的大鼠中均未显著减弱。结果支持这样一种观点,即似乎需要同时刺激D-1和D-2受体才能诱导基底神经节输出出现阿扑吗啡样变化。此外,在正常大鼠中观察到的单独给予D-1和D-2激动剂的作用似乎取决于内源性多巴胺对互补受体亚型的刺激程度。